公司资料
Elevance Health 股价、新闻与催化剂
- 股票代码:
- ELV
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
381.67 USD (-1.84%)
收盘价
最后更新: 2026年10月1日
84.5B USD
市值
股价为何变动
截至 2026年10月1日，ELV 下跌 1.84%，收于 $381.67。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Diversified Health Benefits Company
Elevance Health provides health insurance and related healthcare services across commercial, Medicare, Medicaid, individual, and federal employee markets. Its scale combines regulated health-plan operations with pharmacy, behavioral-health, clinical, and complex-care capabilities.
Health Benefits Segment
The Health Benefits business includes Individual, Employer Group risk-based and fee-based plans, BlueCard, Medicare, Medicaid, and the Federal Employee Program. The segment earns premium and administrative revenue while managing provider networks, medical utilization, and benefit costs.
Carelon Health Services Platform
Carelon houses Elevance Health's diversified healthcare services, including CarelonRx and Carelon Services. These operations provide pharmacy-benefit and specialty-pharmacy services, behavioral health, care delivery, utilization management, and value-based solutions to Elevance members and external customers.
Integrated Whole-Health Model
The company seeks to connect medical benefits, pharmacy, behavioral care, home health, and complex-care support around the same consumer. Data and digital capabilities are used to coordinate interventions, support providers, and manage the cost and quality of care across the member journey.
Large National Consumer Base
Elevance Health's companies serve approximately 104 million consumers through health plans and healthcare services. Its broad membership, provider relationships, and benefit data create a large distribution base for Carelon solutions and population-health programs.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。